• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why China Jo-Jo Drugstores (CJJD) Shares Are Falling

    4/29/24 12:29:30 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples
    Get the next $CJJD alert in real time by email

    China Jo-Jo Drugstores Inc (NASDAQ:CJJD) shares are trading lower by 24% to $2.21 during Monday’s session after the company announced a $1.53 million registered direct offering.

    The company finalized agreements with multiple investors for a registered direct offering, issuing 0.9 million ordinary shares at $1.70 per share, totaling around $1.53 million in gross proceeds. The sale is set to close around April 30, pending standard closing conditions.

    The company plans to utilize the net proceeds for general corporate needs and working capital.

    See Also: Japan Intervenes To Support Struggling Yen: Why Did It Trigger Nikkei 225 Dip? 4 Charts To Watch

    Should I Sell My CJJD Stock?

    When deciding to hold on to or sell a stock, investors should consider their time horizon, unrealized gains and total return.

    Shares of China Jo-Jo Drugstores have decreased by 87.15% in the past year. An investor who bought shares of China Jo-Jo Drugstores at the beginning of the year would take a loss of $2.39 per share if they sold it today. The stock has fallen 31.79% over the past month, meaning an investor who bought shares on Mar. 1 would see a capital loss of $0.44.

    China Jo-Jo Drugstores shares have an all-time high of $247.2, representing 11085.52% upside from current levels.

    Investors may also consider market dynamics. The Relative Strength Index can be used to indicate whether a stock is overbought or oversold. China Jo-Jo Drugstores stock currently has an RSI of 38.72, indicating neutral conditions.

    For access to advanced charting and analysis tools and stock data, check out Benzinga PRO. Try it for free.

    CJJD has a 52-week high of $24.60 and a 52-week low of $1.95.

    Get the next $CJJD alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CJJD

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $CJJD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth

    HANGZHOU, China, Feb. 3, 2025 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced it has entered into definitive agreements for a strategic restructuring initiative to transition into an asset-light, wholesale-focused company, streamlining operations and enhancing profitability. The restructuring involved two major transactions (the "Transactions"): Acquisition transaction: The acquisition of Allright (Hangzhou) Internet Technology Co. Ltd. ("Allright"), a fast-growing company engaged in

    2/3/25 8:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

    HANGZHOU, China, July 30, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to present our financial performance for fiscal year 2024, which reflects our commitment to maintaining a resilient business model in a dynamic market. We achieved a significant 42.1% revenue growth in our wholesale business, a result of our dedicated efforts in target

    7/30/24 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Announces $3.37 Million Registered Direct Offering

    HANGZHOU, China, June 11, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that it has entered into definitive agreements with a number of investors providing for the issuance of 1,980,000 million ordinary shares, at a purchase price of $1.70 per share, in a registered direct offering for an aggregate gross proceeds of approximately $3.37 million. The closing of the sale of the securities is expected to occur on or about June 26, 2024, subject to satisfaction of customary closing co

    6/11/24 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13D/A filed by China Jo-Jo Drugstores Inc.

    SCHEDULE 13D/A - Ridgetech Inc. (0001856084) (Subject)

    3/4/25 4:50:18 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by China Jo-Jo Drugstores Inc.

    6-K - Ridgetech Inc. (0001856084) (Filer)

    3/3/25 9:41:03 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form 6-K filed by China Jo-Jo Drugstores Inc.

    6-K - China Jo-Jo Drugstores, Inc. (0001856084) (Filer)

    2/3/25 8:30:06 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by China Jo-Jo Drugstores Inc.

    SC 13D/A - China Jo-Jo Drugstores, Inc. (0001856084) (Subject)

    11/14/24 4:15:11 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    Amendment: SEC Form SC 13D/A filed by China Jo-Jo Drugstores Inc.

    SC 13D/A - China Jo-Jo Drugstores, Inc. (0001856084) (Subject)

    9/3/24 8:50:20 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    SEC Form SC 13D/A filed by China Jo-Jo Drugstores Inc. (Amendment)

    SC 13D/A - China Jo-Jo Drugstores, Inc. (0001856084) (Subject)

    4/16/24 4:30:11 PM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    Financials

    Live finance-specific insights

    View All

    China Jo-Jo Drugstores Reports Fiscal Year 2024 Financial Results

    HANGZHOU, China, July 30, 2024 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2024. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to present our financial performance for fiscal year 2024, which reflects our commitment to maintaining a resilient business model in a dynamic market. We achieved a significant 42.1% revenue growth in our wholesale business, a result of our dedicated efforts in target

    7/30/24 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Reports Fiscal Year 2022 Financial Results

    HANGZHOU, China, July 28, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced its financial results for the fiscal year ended March 31, 2022. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased with our fiscal year 2022 financial results, which reflect our continued growth momentum that we have achieved overall improvement across all key financial metrics. Compared with fiscal year 2021, our total revenue and gross profit increased by 23.5% and 24.9%, respecti

    7/28/22 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    China Jo-Jo Drugstores Reports First Half of Fiscal Year 2022 Financial Results

    HANGZHOU, China, Jan. 21, 2022 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (NASDAQ:CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products, and healthcare provider in China, today announced its financial results for the first half of fiscal year 2022 ended September 30, 2021. Mr. Lei Liu, Chairman and CEO of Jo-Jo Drugstores, commented, "We are pleased to have delivered a solid performance during the first half of fiscal year 2022 as we navigate through a challenging operating environment affected by multiple COVID-19 surges. We achieved record revenue of $78.48 million, up 26.8% from the same

    1/21/22 9:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples

    $CJJD
    Leadership Updates

    Live Leadership Updates

    View All

    China Jo-Jo Drugstores Announces Strategic Business Restructuring to Strengthen Wholesale Business for Greater Profitability and Growth

    HANGZHOU, China, Feb. 3, 2025 /PRNewswire/ -- China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) ("Jo-Jo Drugstores" or the "Company"), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced it has entered into definitive agreements for a strategic restructuring initiative to transition into an asset-light, wholesale-focused company, streamlining operations and enhancing profitability. The restructuring involved two major transactions (the "Transactions"): Acquisition transaction: The acquisition of Allright (Hangzhou) Internet Technology Co. Ltd. ("Allright"), a fast-growing company engaged in

    2/3/25 8:00:00 AM ET
    $CJJD
    Retail-Drug Stores and Proprietary Stores
    Consumer Staples